ADVM β€” ADVERUM BIOTECHNOLOGIES INC

Ownership history in Qube Research & Technologies Ltd  Β·  11 quarters on record

This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 21,730 -8,949 -29.2% 0.00% $98K β€”
2025 Q2 ADDED 30,679 +14,414 +88.6% 0.00% $66K β€”
2024 Q2 REDUCED 16,265 -25,354 -60.9% 0.00% $112K β€”
2024 Q1 ADDED 41,619 +40,902 +5704.6% 0.00% $588K β€”
2023 Q4 REDUCED 717 -24,250 -97.1% 0.00% $540 β€”
2023 Q3 REDUCED 24,967 -42,597 -63.0% 0.00% $37K β€”
2022 Q3 REDUCED 67,564 -16,322 -19.5% 0.00% $64K β€”
2022 Q2 ADDED 83,886 +60,224 +254.5% 0.00% $101K β€”
2021 Q3 ADDED 23,662 +12,221 +106.8% 0.00% $51K β€”
2020 Q4 REDUCED 11,441 -19,710 -63.3% 0.00% $124K β€”
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ADVM

As of 2025 Q3 β€” sorted by position size

BML Capital Management, LLC 3Y 12.68% Versant Venture Management, LLC 3Y 7Y 1.08% 5AM Venture Management, LLC 3Y 0.9% TCG Crossover Management, LLC 3Y 0.37% Frazier Life Sciences Management, L.P. 3Y 0.28% Pale Fire Capital SE 3Y 0.18% REGENERON PHARMACEUTICALS, INC. 0.12% Soleus Capital Management, L.P. 3Y 0.07% Quinn Opportunity Partners LLC 3Y 7Y 0.01% Waverly Advisors, LLC 3Y 7Y 0.01%
← Back to Qube Research & Technologies Ltd Holdings